Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
RenaissanceRe | RNR | Mar 14, 2025 | 239.65 | +1.45 |
RenaissanceRe G Pref | RNR-G | Mar 14, 2025 | 16.21 | 0.00 |
RenaissanceRe Holding F Pref | RNR-F | Mar 14, 2025 | 22.17 | +0.18 |
Renasant | RNST | Mar 14, 2025 | 34.47 | +3.54 |
ReNew Energy Global A Shares | RNW | Mar 14, 2025 | 6.11 | -0.33 |
Renn Fund | RCG | Mar 14, 2025 | 2.70 | +1.52 |
Renovaro Biosciences | RENB | Mar 14, 2025 | 0.81 | +1.77 |
RenovoRx | RNXT | Mar 14, 2025 | 0.99 | -3.35 |
Rent The Runway A | RENT | Mar 14, 2025 | 4.31 | +9.11 |
Rentokil Initial ADR | RTO | Mar 14, 2025 | 21.86 | +2.20 |
Repare Therapeutics | RPTX | Mar 14, 2025 | 1.10 | -1.79 |
Repay A | RPAY | Mar 14, 2025 | 5.67 | +2.35 |
Repligen | RGEN | Mar 14, 2025 | 150.62 | +5.74 |
Replimune Group | REPL | Mar 14, 2025 | 11.65 | -1.73 |
ReposiTrak | TRAK | Mar 14, 2025 | 19.56 | +1.45 |
Republic Bancorp A | RBCAA | Mar 14, 2025 | 64.81 | +1.95 |
Republic Services | RSG | Mar 14, 2025 | 232.01 | +1.19 |
Research Frontiers | REFR | Mar 14, 2025 | 1.29 | -3.73 |
Research Solutions | RSSS | Mar 14, 2025 | 2.97 | +1.37 |
Reservoir Media | RSVR | Mar 14, 2025 | 7.44 | +0.81 |
ReShape Lifesciences | RSLS | Mar 14, 2025 | 0.64 | +0.08 |
Resideo Technologies | REZI | Mar 14, 2025 | 17.44 | +3.07 |
ResMed | RMD | Mar 14, 2025 | 224.16 | +2.02 |
Resolute Management | RHLDV | Mar 14, 2025 | 31.63 | 0.00 |
Resolute Management | RHLD | Mar 14, 2025 | 32.07 | 0.00 |
Resources Connection | RGP | Mar 14, 2025 | 6.89 | +2.23 |
Restaurant Brands International | QSR | Mar 14, 2025 | 66.06 | +0.49 |
Retail Bull 3X Direxion | RETL | Mar 14, 2025 | 5.76 | +3.97 |
Retail ETF Market Vectors | RTH | Mar 14, 2025 | 220.26 | +1.21 |
ReTo Eco-Solutions | RETO | Mar 14, 2025 | 4.32 | +4.35 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.